Glenn P. Muir, Director at G1 Therapeutics, Inc. (GTHX), bought 50,000 shares at $13.50 ($675K) on 2020-11-18, disclosed to the SEC on 2020-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| STIM | BUY | 2024-08-21 | $25K | — | Filing → |
| STIM | BUY | 2024-08-16 | $19K | — | Filing → |
| STIM | BUY | 2018-07-05 | $680K | — | Filing → |